Abstract: A urinary catheter assembly includes a urinary catheter having a proximal part with an insertion tip, a distal part and a tubular shaft extending between the insertion tip and the distal part. A package having at least a first compartment with an opening is provided to enclose the proximal part and at least a part of the tubular shaft therein in a curved or curled state during storage. A protective sleeve arrangement is arranged around the distal part of the urinary catheter, and a distal end of the protective sleeve arrangement is connected to the urinary catheter, at or in the vicinity of a distal end of the catheter. The protective sleeve arrangement includes at least two sleeves that are telescopically displaceable in relation to each other, and the protective sleeve arrangement is transformable between a retracted position and an extended position.

Abstract: A urinary catheter assembly comprises: a urinary catheter, a tubular case and a sleeve fixedly arranged over at least a part of a non-insertable section of the urinary catheter. The sleeve includes two oppositely arranged openings and a body extending between the opening. In a first position, a storage position, the tubular case is arranged to enclose the insertable section of the urinary catheter and is removably connected to the sleeve and/or to the non-insertable section of the urinary catheter. The body portion of the sleeve is provided with a first engagement member, and the tubular case is provided with a second engagement member, thereby enabling the tubular case, when removed from the non-insertable part of the urinary catheter, to be releasably connected to the sleeve in a second disposition, the second disposition being different from the first disposition. A method for producing a urinary catheter assembly is also disclosed.

Abstract: A urinary catheter assembly comprises a urinary catheter having a proximal part with an insertion tip, a distal part and a tubular shaft extending there between. A package having at least a first compartment with an opening is provided to enclose the proximal part and at least a part of the tubular shaft therein in a curved or curled state during storage. A protective sleeve arrangement is arranged around the distal part of the urinary catheter, a distal end of the protective sleeve arrangement being connected to the urinary catheter, at or in the vicinity of a distal end thereof. The protective sleeve arrangement comprises at least two sleeves being telescopically displaceable in relation to each other, wherein the protective sleeve arrangement is transformable between a retracted position and an extended position.

Abstract: A medical device assembly comprises a medical device, such as a urinary catheter, comprising an insertable part and a non-insertable part. The insertable part comprises an elongate shaft provided with a hydrophilic coating or surface. The assembly further comprises a wetting fluid compartment arranged to encircle at least a part of the medical device, and preferably at least a part of the non-insertable part, and an aqueous fluid arranged in the wetting fluid compartment. At least one of the aqueous fluid and the hydrophilic coating or surface comprises at least one surfactant. The hydrophilic coating or surface is maintained essentially separated from the aqueous fluid, and arranged to become wetted by movement of the elongate shaft through the wetting fluid compartment.

Abstract: Methods for treating a human subject who has X-linked Retinitis Pigmentosa (XLRP) or another clinically-defined ophthalmological condition due to a loss-of-function mutation in the gene encoding the retinitis pigmentosa GTPase regulator (RPGR) protein, the method comprising administering to the subject a nucleic acid comprising an adeno-associated viral vector comprising an abbreviated human RPGR cDNA.

Abstract: Methods for treating a human subject who has X-linked Retinitis Pigmentosa (XLRP) or another clinically-defined ophthalmological condition due to a loss-of-function mutation in the gene encoding the retinitis pigmentosa GTPase regulator (RPGR) protein, the method comprising administering to the subject a nucleic acid comprising an adeno-associated viral vector comprising an abbreviated human RPGR cDNA.

Abstract: There is disclosed an adaptive data transfer protocol, system and method.

Abstract: A urinary catheter assembly comprises: a urinary catheter, a tubular case and a sleeve fixedly arranged over at least a part of a non-insertable section of the urinary catheter. The sleeve includes two oppositely arranged openings and a body extending between the opening. In a first position, a storage position, the tubular case is arranged to enclose the insertable section of the urinary catheter and is removably connected to the sleeve and/or to the non-insertable section of the urinary catheter. The body portion of the sleeve is provided with a first engagement member, and the tubular case is provided with a second engagement member, thereby enabling the tubular case, when removed from the non-insertable part of the urinary catheter, to be releasably connected to the sleeve in a second disposition, the second disposition being different from the first disposition. A method for producing a urinary catheter assembly is also disclosed.

Abstract: Methods for treating a human subject who has X-linked Retinitis Pigmentosa (XLRP) or another clinically-defined ophthalmological condition due to a loss-of-function mutation in the gene encoding the retinitis pigmentosa GTPase regulator (RPGR) protein, the method comprising administering to the subject a nucleic acid comprising an adeno-associated viral vector comprising an abbreviated human RPGR cDNA.

Abstract: Methods for treating a human subject who has X-linked Retinitis Pigmentosa (XLRP) or another clinically-defined ophthalmological condition due to a loss-of-function mutation in the gene encoding the retinitis pigmentosa GTPase regulator (RPGR) protein, the method comprising administering to the subject a nucleic acid comprising an adeno-associated viral vector comprising an abbreviated human RPGR cDNA.

Abstract: This invention relates to methods for treating subjects with vision loss due to advanced Leber Congenital Amaurosis (LCA), e.g., LCA6, which is due to loss-of-function mutations in the gene encoding the retinitis pigmentosa GTPase regulator interacting-protein-1 (RPGRIP1) protein.

Abstract: A spotter mirror mountable to a reflector has a back, a front reflecting surface, and a locator. The locator facilitates locating the spotter mirror at a predetermined location on the reflector such that the back of the spotter mirror abuts the reflector.

Abstract: An apparatus (device) and system, an animal safety collar, is disclosed; safety collar with built-in emergency leash and automatic tension control or (in alternative embodiments) an animal safety collar to remotely track and communicate with a loose animal that has broken its primary leash and has roamed to an unknown distant location. Also disclosed is an accessory pouch disposed on the collar and at least one item placed in or on said accessory pouch selected from the group consisting of battery, solar photovoltaic cell, video camera, audio microphone, Global Positioning Satellite device, radio frequency identification chip, video recorder, audio recorder, cell phone, information card/chip/microfiche, radio, remote-activated clicker, peripheral components and other user-defined means for and types of communication, identification and tracking. The device may also be used as a primary leash/collar for animals.

Abstract: A display package for a bottle is presented having a relatively short base section and a folded wrap-around section. The base section has a top with a hole adapted for receiving the bottom of the bottle. The wrap-around section extends from the back of the base section over the top of the bottle and down to the front of the base. The top of the wrap-around section is shorter in length than the largest diameter of the bottle displayed in the packaging. A window in the front of the wrap-around section allows the upper-front portion of the bottle to extend through the window. In addition, the wrap-around section leaves majority of the bottle exposed through the open sides of the tent-like structure formed by the wrap-around section.